Interested in any of the investor opportunities displayed here?

Get future investor opportunities straight to your inbox

Project Vulcan

£100 m equity and debt funding

Series A growth

The advent of Covid-19 has given further pressure for the restructuring of how Care Homes operate and is encouraging many privately owned homes to come on to the market. Vulcan will specialise in the fastest-growing and most profitable sector – residential care for dementia sufferers. It combines further opportunities to enhance profitability with higher occupancy levels, regular fee increases and reduced dependency on agency staff.

FoodChek

$10.0 m Funding

Growth Capital

FoodChek is an established and successful Canadian biotech company specializing in the ever-growing food safety market. Demand for Food Safety Bacterial pathogen testing and Viral testing for Covid-19 as well as demand on the world’s laboratories using enrichment media has soared. FoodChek has the solution to these issues; using their tried and tested enrichment media product, FoodChek has developed a COVID-19 testing kit that offers superior quality, as requested by the Canadian government.

UVC Allianz GmbH

£1 m equity and debt funding

Development and exploitation

UVC Allianz GmbH produces and distributes highly specialized equipment for the destruction of all kinds of germs (bacteria, viruses (incl. coronavirus), etc.), in hospitals by means of UV radiation in the C wavelength range. A new UVC LED medical air sterilizer is currently under development and will be available on the market within 3 months in different sizes for various applications.

Disarmco

£25 m debt funding

Growth capital

Disarmco Holdings Limited is a UK-based company which creates products and technologies for the disposal of unwanted munitions – through humanitarian and environmentally safe means. Disarmco is now building and integrating a system to dispose of large stockpiles of obsolete munitions to capture a highly lucrative market.

Grand Cascade Group

£20 m equity funding

Buy and build

Grand Cascade Group is an investment consortium engaged in the acquisition and management of outstanding care homes both in the UK and internationally. The retirement living private market is to increase by over 50% to £44bn by 2022. 86.4% of market share is held by small operators. The industry is still highly fragmented in the UK, therefore there is an opportunity to consolidate.

Hexa Resources

US$12 m funding

Acquisition & growth

Hexa Resources is a new UK based private coloured gemstone business, focused on mining and trading emeralds in Colombia, and Brazil, looking to become a leading player in the wholesale coloured gem market. The company has already raised ca. US$1.7 million of 1st and 2nd round funds and are now looking to raise an extra US$12 million.

Iolair International

£160 m equity and debt funding

Fund creation

Iolair International wishes to create a mining investment fund, which would raise capital for small gold mining companies that struggle to obtain loans from banks under present difficult market conditions. The main objective is to create a specialist investment fund which will focus on lending to small mining companies.

LDN UTD

£1 m equity funding

Seed

LDN UTD is the first e-sports social enterprise. They are a team for e-sports and gaming fans who believe that gaming can and should be a platform for something greater. The company develops incredible players from all backgrounds and offers them a platform to play at their best.

TRUEinvivo

£1.25 m equity and debt funding

Start-up

TRUEinvivo is an in-body radiation measurement company focused on reducing patient harm in radiotherapy. They have 5 hospital partners, 6 international projects and patented CE-marked devices. The company is looking to raise up to £1.25 million of equity (£100k pre-emptions and £150k committed).

Green Bio Energy plc

£30 m Green Bond

Fundraising

Green Bio Energy Plc is a 100% subsidiary of Agrofarm London Ltd. The company are already operating three profitable power plants in Northern Italy and are looking to take further advantage of the Italian Government’s generous schemes regarding renewable energy. The company is looking to issue a £30m Green Bond to be listed on the Vienna Stock Exchange, which will provide a fixed income of 7.75% payable quarterly in arrears for a term of 5 years. The bond has been rated as ‘BBB’ by ratings agency Egan-Jones.

H2 Greenforce

$10 m funding

Growth capital

This is a unique opportunity to invest in the H2 Greenforce LLC, a global developer of Green Hydrogen and eMobility Infrastructure. Founded in 2020, the Company designs, develops and operates a unique, patented and innovative, self sustaining application for truly 100% green hydrogen and e-mobility infrastructure. Today, the management team has identified four areas of focus to achieve a revenue stream from sale of green hydrogen and electric / hybrid charging as well as development fees. The Company plans to be cash positive in Q1 2022 with double digit growth in subsequent quarters.

Kāriki Pharma

NZ$2 m new capital

Seed & start-up

Kāriki Pharma is on track to be the first company to enter the New Zealand medicinal cannabis market and export products developed in New Zealand. The company is the only licensed company to have direct experience distributing medicinal cannabis products internationally. Letters of Intent for off-take arrangements are in place with cannabis cultivation facilities to provide Kāriki Pharma with sufficient starting material before developing its own growing capabilities. After entering the local market, Kāriki Pharma aims to expand its manufacturing capability to meet the large international demand for New Zealand-produced medicinal cannabis products.

VoiceSage

£10 m equity and debt funding

Series A growth

VoiceSage provide outstanding services to blue chip clients in the UK and elsewhere, including customer communications technology around billing, service, surveying, marketing, support and delivery operations. VoiceSage provides a solution that is proven over recent years to drive KPI supported quality improvement and cost efficiencies for clients. There is significant scope for international expansion and strategic acquisitions.